
    
      Generic emtricitabine(FTC) has been approved for treatment of naive chronic hepatitis B(CHB)
      patients in China. Yet data are limited for this agent plus adefovir dipivoxil in cirrhosis
      patients. The investigators design this trial to test the effect of FTC plus adefovir
      dipivoxil in Chinese naive compensated and decompensated HBV related cirrhosis patients.
    
  